Loading…
← CockpitCompetitor Analysis › DCTH Delcath Systems, Inc.Open in the cockpit ↗

Delcath Systems, Inc.DCTHCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical Specialties
Momentum leader 97
Mkt cap
$685M
US dollars, full cap
Free float
93%
of shares outstanding
$/day
$15.2M
20-day average traded
Fwd P/E
358.9×
forward earnings
ROIC−WACC
+6.1 pp
WACC 8.1%
Hurdle
-87 pp
Req g minus delivered
Next earnings
132 days
30 Mar 2027
Close · USD$19.70
1D+1.7%
1W-9.5%
1M+33.5%
3M+17.6%
6M+75.4%
YTD+95.0%
1Y+128.8%
ATR %5.5%
Beta1.76
52w lowhigh12.5% off high

What Delcath Systems does

Employees: 156

Delcath Systems at a glance

Size Delcath Systems (DCTH) is a United States Health Care company (Medical Specialties) with a market value of $685M, the 2475th largest of 3,085 United States companies the cockpit tracks. Shares closed at $19.70 on 18 Nov 2026.

Performance Over six months the shares gained 75.4%, against -15.1% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 38.1% over the last twelve months (peer median +14.8%); the operating margin is 5.2% (peer median 15.6%).

Valuation It trades at 358.9× forward earnings against a peer median of 20.5× (most expensive of 18).

Price implies For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +120%, so the hurdle is -87 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 6.1 points above its cost of capital (8.1% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026DCTH 172Peer median 86
Six months, rebased to 100: Delcath Systems against the median of its 20 peers (local-currency closes).

Delcath Systems financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$110M$85.2M$37.2M$2.06M$2.72M
Revenue growth—+129%+1,702%-24%—
Gross profit$96.3M$73.4M$31.0M$1.30M$1.46M
EBITDA$6.29M$1.01M-$12.2M-$38.1M-$33.3M
Net income$6.65M$2.70M-$26.4M-$47.7M-$36.5M
Free cash flow$20.1M$21.0M-$19.2M-$31.3M-$25.2M
Capital expenditure$2.88M$1.55M$559,000$58,000$209,000
Total debt$2.41M$936,000$1.04M$11.0M$17.0M

Quarterly statements and history in the cockpit →

Delcath Systems competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%49100000287668838968808530123415017575688410300326SNT300622QDEL301122688179301367600855300453DCTH6-month return →1-month return →
Up and to the right = strong over both horizons. Delcath Systems is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×200×00287668838968808515017575688410300326300622QDEL3011221789603108DCTHRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Delcath Systems is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%00287668838968808530123415017575688410300326SNT1789DCTHGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Delcath Systems is the large dot.

Delcath Systems competitors and peer comparison

How Delcath Systems compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Delcath Systems against its 20 peers (data as of 18 Nov 2026)
MeasureDCTHPeer medianRank in peer set
1-month return+33.5%-8.9%highest of 21
6-month return+75.4%-15.1%2nd highest of 21
Distance from 52-week high-12.5%-35.5%3rd highest of 21
Revenue growth (TTM)+38.1%+14.8%4th highest of 21
Operating margin5.2%15.6%9th lowest of 21
Forward P/E358.9×20.5×most expensive of 18
Growth the price implies (Req g, 7 yrs)33.4%3.4%most demanding of 17
Growth delivered (Del g)+120.2%+12.9%highest of 17
Hurdle (Req g minus delivered)-86.8 pp-11.1 ppleast demanding of 17
ROIC minus cost of capital+6.1 pp+3.8 pp9th highest of 21
EV / EBITDA92.8×8.5×most expensive of 7
Net debt / EBITDA-16.2×-1.2×least indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
Shanghai Kinetic Medical 300326.SZChina$662M-10%-28%17%26.0×6.6%-1.9%
Synektik SNT.WAPoland$662M+10%+32%24%13.8×0.2%+47.5%
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
QuidelOrtho QDELUnited States$657M-20%-5%-2%10.7×n/an/a
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
AK Medical 1789.HKHong Kong$642M-23%+16%26%10.5×-11.5%+6.7%
Shanghai Aladdin Biochemical Technology 688179.SSChina$736M-37%+39%24%27.4×17.1%+24.2%
BMC Medical 301367.SZChina$737M-17%+37%17%18.7×-1.5%+15.6%
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%n/an/an/a
InMode INMDUnited States$741M-8%+2%18%9.8×-10.8%+12.4%
Shanghai Runda Medical Technology 603108.SSChina$744M-36%-12%-2%20.5×20.3%-0.2%
Jiang Xi Sanxin Medtec 300453.SZChina$744M-3%+12%18%16.2×-1.9%+11.8%

Questions

Which companies are Delcath Systems's closest peers?
The cockpit's peer set: Livsmed (491000.KS), Shenzhen Sunnypol Optoelectornics (002876.SZ), Shenzhen Lifotronic Technology (688389.SS), Shanghai Sanyou Medical (688085.SS), Anhui Hongyu Wuzhou Medical Manufacturer (301234.SZ), Shanghai INT Medical Instruments (1501.HK), Japan Lifeline (7575.T), SWS Hemodialysis Care (688410.SS).
Is Delcath Systems expensive compared with its peers?
On forward p/e it trades at 358.9× against a peer median of 20.5×, most expensive of 18 in its peer set. For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +120%, so the hurdle is -87 pp: the price already allows for a slowdown.
How has Delcath Systems stock performed?
Over six months to 18 Nov 2026 the shares returned +75.4% against -15.1% for the median peer; over one year +128.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.